These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6096336)

  • 1. Pathogenicity of a modified-live pseudorabies vaccine virus in lambs.
    Clark LK; Molitor TW; Gunther R; Joo HS
    J Am Vet Med Assoc; 1984 Dec; 185(12):1535-7. PubMed ID: 6096336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vaccination on lesion development in pseudorabies virus-challenged swine.
    Alva-Valdes R; Glock RD; Kluge JP; Keune CM
    Am J Vet Res; 1983 Apr; 44(4):588-95. PubMed ID: 6307084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced pseudorabies in lambs.
    Van Alstine WG; Anderson TD; Reed DE; Wheeler JG
    J Am Vet Med Assoc; 1984 Aug; 185(4):409-10. PubMed ID: 6088455
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
    van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of replication and virulence of attenuated pseudorabies virus in swine.
    Newby TJ; Carter DP; Yoon KJ; Jackwood MW; Hawkins PA
    J Vet Sci; 2002 Jun; 3(2):61-6. PubMed ID: 12441673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abortion induced by cell-associated pseudorabies virus in vaccinated sows.
    Nauwynck HJ; Pensaert MB
    Am J Vet Res; 1992 Apr; 53(4):489-93. PubMed ID: 1316724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
    Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
    Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro reactivation of latent pseudorabies virus in pigs born to vaccinated sows.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Mar; 45(3):567-71. PubMed ID: 6324622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus.
    Ferrari M; Gualandi GL; Corradi A; Monaci C; Romanelli MG; Losio MN; Cantoni AM; Pratelli A
    Comp Immunol Microbiol Infect Dis; 2000 Jan; 23(1):15-26. PubMed ID: 10660255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response of pigs to inactivated monovalent and bivalent vaccines for porcine parvovirus and pseudorabies virus.
    Mengeling WL; Gutekunst DE; Pirtle EC
    Am J Vet Res; 1980 Oct; 41(10):1569-71. PubMed ID: 6261613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
    Firkins LD; Weigel RM; Biehl LG; Hahn EC
    Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication of pseudorabies virus from three large swine herds achieved by management intervention and use of a vaccine with a deletion for glycoprotein I.
    Lehman JR; Weigel RM; Hall WF; Taft AC
    J Am Vet Med Assoc; 1994 Dec; 205(11):1581-7. PubMed ID: 7730129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of dUTPase-deficient pseudorabies virus for the natural host.
    Jöns A; Gerdts V; Lange E; Kaden V; Mettenleiter TC
    Vet Microbiol; 1997 May; 56(1-2):47-54. PubMed ID: 9228681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.